Hormonal
Adiponectin enhances insulin signaling in target tissues by promoting the binding of IRS1/2 to the insulin receptor via the adaptor protein APPL1, thereby sensitizing cells to insulin.
This mechanism explains why metabolic health is interconnected. It suggests that factors affecting the APPL1 protein or insulin receptor substrate binding could impact how well your body responds to insulin. While there is no direct intervention for APPL1 yet, maintaining metabolic health supports these intricate signaling networks.
APPL1 promotes IRS1/2 binding to the insulin receptor... This process plays a key role in improving insulin sensitivity
Why this rating
Based on mechanistic studies in cell lines and knockout mice; direct human therapeutic application is not yet established.
Source
Adiponectin signaling and function in insulin target tissues
Hong Ruan et al. · Journal of Molecular Cell Biology · 2016
DOI 10.1093/jmcb/mjw014
More from this paper
- Adiponectin improves insulin sensitivity in skeletal muscle and liver by activating AMPK and PPAR-alpha pathways, leading to increased fatty acid oxidation and reduced hepatic glucose production.Moderate
- Adiponectin is not a viable direct therapeutic drug due to its high physiological concentration requirements, multiple oligomeric forms, and short half-life, but small-molecule activators like AdipoRon show promise.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →